Search

Author/Creator Rapoport, Bernardo L

3. Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in patients with cancer: two randomised, active-controlled, double-blind, phase 3 trials. Issue 9 (September 2015)

Authors:
Rapoport, Bernardo L; Chasen, Martin R; Gridelli, Cesare; Urban, Laszlo; Modiano, Manuel R; Schnadig, Ian D; Poma, Allen; Arora, Sujata; Kansra, Vikram; Schwartzberg, Lee S; Navari, Rudolph M
Journal:
Lancet oncology
Issue:
Volume 16:Issue 9(2015:Sep.)
Page Start:
1079
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in patients with cancer: two randomised, active-controlled, double-blind, phase 3 trials. Issue 9 (September 2015)

Authors:
Rapoport, Bernardo L; Chasen, Martin R; Gridelli, Cesare; Urban, Laszlo; Modiano, Manuel R; Schnadig, Ian D; Poma, Allen; Arora, Sujata; Kansra, Vikram; Schwartzberg, Lee S; Navari, Rudolph M
Journal:
Lancet oncology
Issue:
Volume 16:Issue 9(2015:Sep.)
Page Start:
1079
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: a randomised, active-controlled, double-blind, phase 3 trial. Issue 9 (September 2015)

Authors:
Schwartzberg, Lee S; Modiano, Manuel R; Rapoport, Bernardo L; Chasen, Martin R; Gridelli, Cesare; Urban, Laszlo; Poma, Allen; Arora, Sujata; Navari, Rudolph M; Schnadig, Ian D
Journal:
Lancet oncology
Issue:
Volume 16:Issue 9(2015:Sep.)
Page Start:
1071
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: a randomised, active-controlled, double-blind, phase 3 trial. Issue 9 (September 2015)

Authors:
Schwartzberg, Lee S; Modiano, Manuel R; Rapoport, Bernardo L; Chasen, Martin R; Gridelli, Cesare; Urban, Laszlo; Poma, Allen; Arora, Sujata; Navari, Rudolph M; Schnadig, Ian D
Journal:
Lancet oncology
Issue:
Volume 16:Issue 9(2015:Sep.)
Page Start:
1071
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗